Please login to the form below

Not currently logged in
Email:
Password:

Wyeth makes new hires

Wyeth makes two new appointments to its Women's Health Care Business Unit

The pharmaceutical division of Wyeth has appointed Cathy Kerzner to the position of senior vice-president and general manager of the company's Women's Health Care Business Unit.

Kerzner will lead the commercial aspects of Wyeth's portfolio of the unit's products on a global basis and will report to Joseph Mahady, president of global businesses of Wyeth Pharmaceuticals.

She had spent 14 years with Wyeth in a number of commercial capacities before advancing to the position of vice-president of business strategy and then vice-president of commercial strategy for Cardinal Health. Kerzner founded EKR Therapeutics, a US-based start-up specialty pharmaceutical company.

In addition, Wyeth has promoted Dr Michael Dey to the position of president of scientific affairs for women's health. Dey will focus on efforts to advance the understanding of the science that supports both new and existing female healthcare products at the firm. He will also report to Mahady.

Dey joined Wyeth-Ayerst R&D in 1984 and headed Wyeth's generic pharmaceutical business for eight years. Since 2001, he has served as president and general manager of the Women's Health Care arm.

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics